Sale processes for Kersia and Solina have been halted due to valuation mismatches between buyers and sellers, in a fresh indication of the challenges faced by the private credit industry when it comes to getting deals over the line.
Astorg had mandated Goldman Sachs and another advisor to lead the sale process for Solina, which was marketed at roughly €300 million EBITDA, according to sources. “The sale process for Solina seems to have stalled as the offers failed to meet the seller’s valuation expectation,” one source said, adding that the company might come back to the market next year, but for now the process appears to have been pulled.
Another source said that — although the sponsor received several offers and interest was strong — management believes the offers do not fully reflect the value of Solina.
As for Kersia, IK Partners had engaged BofA and Sycomore Corporate Finance to advise on the sale of the French food safety specialist, which was being marketed at EBITDA of around €150 million. The process is also said to have stalled amid a valuation mismatch, market sources said.
IK Partners and Astorg declined to comment.
M&A obstacle
Valuation mismatches have been one of the biggest obstacles to a pick-up in M&A activity over the last few years, set against the backdrop of a difficult macro environment. And although some of the macro issues — such as tariff concerns and the war in Ukraine — have been adjusted for, buyers and sellers have not been able to find common ground for some valuations, especially around assets that were sold in 2020-2021.
Another market participant noted he has seen at least two other sale processes recently halted for similar reasons, with sellers unwilling to accept the valuations offered, and has therefore decided to hold the asset for longer.
Both Kersia and Solina are loan names. Solina is a cross-border name that was last in the market in January, when it closed a €920 million repricing and add-on due July 2028 at E+350. In June, Kersia closed a €100 million add-on to its E+375 term loan at 100.25 to support an acquisition. The increase took the group’s euro term loan to roughly €624 million, and the facility sits alongside a £40 million tranche.
Shannon Fagan/Getty Images
Learn about our editorial standards.